Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-0458
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

771. Overcoming Resistance to Antibody Targeted Therapy in Cancer Using Gene-Modified T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2020English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-Pd-1 Therapy

Cancer Research
Cancer ResearchOncology
2019English

Phase I Study of Nivolumab, an Anti-Pd-1 Antibody, in Patients With Malignant Solid Tumors

Investigational New Drugs
OncologyPharmacology
2016English

Transduction of Human Dendritic Cells With Adenovirus Encoding Anti-Pd-1 Reduces PD-1 Expression on Co-Cultured T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

LPA4-mediated Vascular Network Formation Increases the Efficacy of Anti-Pd-1 Therapy Against Brain Tumors

Cancer Research
Cancer ResearchOncology
2018English

Modified T Cells Home to Brain Tumors

Cancer Discovery
Oncology
2018English

Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway

Forum on Immunopathological Diseases and Therapeutics
BiochemistryBiotechnologyGeneticsMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy